NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...
Fierce Biotech16h
'Patently illegal': NIH and HHS face new lawsuit over $1.1B in revoked research grants
The cuts impact more than $2.4 billion in grant money, including $1.3 billion in grant money already spent on projects ...
Science Daily16h
In pancreatic cancer, a race against time
Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...